Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-24 Tax Withholding | 2024-02-27 5:13 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | 10,484 | $1.13 | 846,188 (Direct) | View |
| 2024-01-22 Option Award | 2024-01-24 4:40 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | 712,500 | $0 | 856,672 (Direct) | View |
| 2023-11-25 Tax Withholding | 2023-11-28 4:16 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-Chief Development Officer | 1,462 | $0.3821 | 139,172 (Direct) | View |
| 2023-08-25 Tax Withholding | 2023-08-29 4:13 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-Chief Development Officer | 1,462 | $0.77 | 140,634 (Direct) | View |
| 2023-05-25 Tax Withholding | 2023-05-30 4:43 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-Chief Development Officer | 1,462 | $1.33 | 137,096 (Direct) | View |
| 2023-02-25 Tax Withholding | 2023-03-06 5:08 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-Chief Development Officer | 9,834 | $2.66 | 387,933 (Direct) | View |
| 2023-02-24 Option Award | 2023-03-06 5:08 pm | N/A 2033-02-23 | SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-Chief Development Officer | 302,813 | $0 | 387,933 (Direct) | View |
Ownership | 2022-09-19 7:24 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-Chief Development Officer | 0 | $0 | 419,581 (Direct) | View |